PTCT
PTC Therapeutics Inc
63.20$
-0.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -5.8% | -11.4% | -6.7% | +28.7% | +14.4% | +437.4% | +47.5% | +23.4% | +163.7% | -24.4% | +100.9% | +83.6% | -68.0% | -48.7% | |
| – | – | – | -18.8% | +268.3% | +129.1% | +76.0% | +3.0% | -12.7% | +8.8% | +26.7% | +66.9% | +47.2% | +6.6% | +18.9% | -43.1% | -0.1% | |
| – | – | – | – | – | +44.5% | +70.8% | +16.9% | -11.8% | +62.0% | +62.9% | -33.5% | +253.8% | -50.6% | – | – | – | |
| – | – | – | – | – | – | -64.4% | -290.7% | – | +7.4% | +43.8% | +80.7% | -164.4% | – | – | – | -146.7% | |
| – | -14.2% | -82.8% | +14.3% | +348.2% | +451.5% | -41.7% | -34.7% | +74.6% | +400.8% | +192.6% | +23.2% | +52.4% | +78.7% | -20.9% | -38.4% | +304.1% | |
| – | – | – | -100.7% | +67,648.5% | +13.6% | -85.7% | – | -87.4% | -424.9% | +808.7% | +45.0% | – | +32.4% | -160.9% | – | -2,051.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +22.6% | -96.3% | -88.9% | +125.4% | +5,929.8% | +162.7% | -70.0% | -77.7% | +207.7% | – | – | – | |
| – | – | – | – | – | -99.0% | – | -72.5% | -101.1% | – | +0.0% | -110.8% | -92.3% | – | -317.5% | -99.5% | +8.1% | |
| – | +97.8% | -127.0% | – | +736.4% | +26.5% | -35.0% | -99.4% | +4,468.0% | +197.6% | +366.1% | +9.1% | -96.9% | +704.5% | +284.9% | -60.4% | +29.4% | |
| – | – | – | – | – | +170.6% | -75.9% | -96.4% | +17,783.3% | +7.9% | +118.4% | -162.9% | – | – | +218.5% | -41.1% | +9.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.